Text Size

Chronic Migraine Epidemiology and Outcomes Study

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Allergan
ClinicalTrials.gov Identifier:
NCT01648530
First received: July 20, 2012
Last updated: July 23, 2012
Last verified: July 2012
History of Changes
  Purpose

This is a population internet-based study to characterize migraine clinical course and impact on family.


Condition
Migraine Disorders

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

MedlinePlus related topics: Migraine
U.S. FDA Resources

Further study details as provided by Allergan:

Primary Outcome Measures:
  • Migraine Disability Assessment (MIDAS) [ Time Frame: 13 Months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Subject Quality of Life Questionnaire [ Time Frame: 13 Months ] [ Designated as safety issue: No ]

Estimated Enrollment: 15000
Study Start Date: July 2012
Estimated Study Completion Date: November 2013
Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
Migraine
Subjects with migraine and household members

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Subjects with chronic migraine

Criteria

Inclusion Criteria:

  • History of migraine
  • U.S. Member of Survey Panel
  • Household member of study participant
  • Ability to complete internet-based questionnaires

Exclusion Criteria:

  • No access to internet
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01648530

Sponsors and Collaborators
Allergan
Investigators
Study Director: Medical Director Allergan
  More Information

No publications provided

Responsible Party: Allergan
ClinicalTrials.gov Identifier: NCT01648530     History of Changes
Other Study ID Numbers: GMA-BTX-12-470
Study First Received: July 20, 2012
Last Updated: July 23, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Migraine Disorders
Headache Disorders, Primary
Headache Disorders
 Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on June 17, 2013